Article
Role of TDP2 in the repair of DNA damage induced by the radiomimetic drug Bleomycin
28 Mar 2025
Abstract excerpt
Abstract Background Bleomycin (Bleo) is a glycopeptide with potent antitumor activity that induces DNA double-strand breaks (DSBs) through free radical generation, similar to ionizing radiation (IR). Therefore, Bleo is considered a radiomimetic drug. However, differences in DNA repair mechanisms between IR- and Bleo-induced DNA damage have not been fully elucidated. Therefore, in the present study, we examined a...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
